I arrived the US from Nigeria in June, 2020 at the height of the COVID pandemic following my dreams of becoming a US-trained physician. Residency has been one of the most refining phases of my life. Thank you
@IMCreighton
. Looking forward to an even brighter future.
#MedTwitter
Last day on the BMT service and I’m grateful for the rich educational experience in the last month. I saw many things from cellular therapy: engraftment syndrome, CRS,ICANS, HLH, disseminated adeno, cGVH etc. Thank you
@bdermanmd
Dr. Satyajit Kosuri
@UChicagoHemOnc
#MedTwitter
My journey to Hematology and Oncology started as a young girl growing up in Northern Nigeria with many friends with sickle cell disease. The desire to help my friends strongly influenced my decision to pursue a career in Hem/Onc...... a thread
#myjourneytohemonc
@HemOncFellows
One of my biggest lessons in my journey to becoming an oncologist is “who you marry matters a lot”. Partners are often the strongest advocates for our patients. From taking them to appointments, listening and asking questions/ taking care of them through difficult treatments 💕
Thank you to everyone who stopped by my poster yesterday at
#ASCOQLTY22
. I am happy to be a part of the future of Oncology.
You can read the full published abstract here:
Who's speaking at Eureka Talks? 💡 Hear about The Gift of a Cell from
@UChicago
's Faith Abodunrin 🔬. Vote for your top talks and meet cool researchers on May 23! Tap the link to join the fun! 👈
This was such a FUN and educational debate. We discussed some of the biggest and possibly practice changing abstracts in
#lcsm
(lung cancer) space. The best way to end my
#ASCO24
Thanks for having us
@OncLive
@rajatthawani
Super proud of our case report published in the Annals of Medicine and Surgery. I am grateful to have worked with a budding cardiologist and superstar co-resident
@Mahmoud_Ismayl
@CUMCIMResearch
@IMCreighton
. Read the full case report here:
I am thrilled to launch the "Fellowship Excellance Webinar" hosting fellows across US sharing tips with new fellows🙂
📆 May 11th, 2024 - Saturday
⏲️ 7 pm CST
Dr Abodunrin
@your_hemoncdoc
is a fellow at
@UCHemOncFellows
program & completed residency training at
@IMCreighton
.
'Excited to be accepted for a presentation at
@ASCO
's Quality Care Symposium. Thanks to my mentors
@MridulaKrishnan
, Dr Peter Silberstein for your help on this project. As always, manuscript is on its way. Also working on an abstract /project for
@ASH_hematology
.
💥This exciting session💥 is specially charted for the newly matched Heme-Onc fellows🙂 How to navigate the first 6 months of fellowship. Dr Abodunrin
@your_hemoncdoc
from
@UCHemOncFellows
will be sharing her perspectives with incoming fellow Dr
@BeatriceTorere
at
@HemeoncOhsu
🌟
Welcome to our new Chief Fellow, Dr.
@AlexandraRojek
!! We know she will do great things this year and are thrilled for her to be in this leadership role! Congratulations, Dr. Rojek!
@UCHemOncFellows
Another great year at Annual Updates from ASH for our fellows to learn the latest updates in heme malignancies, and present some of their own case-based clinical trial review!
@UChicagoHemOnc
@UChicagoLeuk
@UChicagoCME
After almost 7 years of training as a peruvian
#IMG
and 1 year of job searching, many job virtual and in person interviews, ups and downs, failures (more downs), multiple (like a lot) rejections, being told "you are not good enough" "You wont make it", "you come from a small
I went to visit a pt in the hospital
The family expressed how much they prayed for an oncologist like me
I cried, as I am the lucky one
The pts God puts in my path touch my spirit & make me a better person/doctor every day
I am thankful for the lives I am blessed to touch
I made it to the airport with my poster after a short day on the Psychiatry consult service. Grateful to be able to contribute my quota to Oncology and looking forward to making you friends.
#ASCO2023
I enjoyed writing this review article on solitary fibrous tumors of the pleura for
@StatPearls1
. Please read the full article and learn more here:
#medtwitter
#hemonctwitter
I remember the overwhelming welcome Enhertu received at
@ASCO
general meeting in June. One of the many moments that reassured me that I was going into a one-of-a- kind field.
#journeytohemonc
#hemoncapplicant
Just Out‼️
@US_FDA
🇺🇸approves Enhertu in the tx of unresectable/metastatic HER2-low
#BreastCancer
☑️The 1️⃣st first approved tx targeted 🎯 to HER2-low breast
#mattcancer
July means our newly minted 2nd year fellows are enjoying a clinical break and turning to research, and we're excited for our brand new first years who are starting their rotations and acclimating to hem/onc with "Bone Marrow Bonnie" and our PD, Dr. Cohen!
@UChicagoHemOnc
A great oncologist must first be a great internist.
Here is a pearl from my study for the IM board 👉
Indications for catheter removal in CVC infections:
Severe sepsis, suppurative thrombophlebitis, endocarditis, persistent bloodstream infection > 72 hrs after appropriate abx
how do our first year fellows fight the dip of winter in Chicago? having fun with their foundational oncology lectures, and finding the funny moments, of course!
@your_hemoncdoc
@SamuelJYates
@theproffermd
'Excited to be accepted for a presentation at
@ASCO
's Quality Care Symposium. Thanks to my mentors
@MridulaKrishnan
, Dr Peter Silberstein for your help on this project. As always, manuscript is on its way. Also working on an abstract /project for
@ASH_hematology
.
Great late-breaking abstract session moderated by
@myeloidmalig
and Dr. David Garcia this morning. I was particularly fascinated by the results of the ALPINE trial comparing Zanubrutinib and Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia.
#ASH2022
Hey
#Hemonc
#Fellowship
applicants,
We are planning to host a session on tips for Hemonc fellowship application. What kind of speakers do you want to see in the panel? Let us know in the comments and we will try to include speakers with that background.
#medtwitter
Today's IM pearls on my road to becoming an oncologist 👉🏽
Treatment in febrile neutropenia should include mono therapy with an anti-pseudomonas beta-lactam (Pip-Tazo, Cefepime) in the inpatient setting.
I found this article by folks
@UNMC_ID
very useful
@TumorBoardTues
@hoperugo
2/20
#TumorBoardTuesday
What is HER2-low
#BreastCancer
?
🔹 HER2 IHC 1+ or 2+/ISH neg
🔹 Large % of HR+ BC (~67%), less in TNBC
🔹 Prognosis/biology indistinct from HER2-0
🔹 Unreliable IHC scoring; need better tests!
🔹 NOT a BC subtype; but targetable
Happy ‘thank a resident/fellow day’ to all trainees. What a great time in our lives and so much to look forward to in the future.
#graduatemedicaleducation
While studying medicine more than 4,000 miles away from home in Hungary, my interest grew further. How I loved learning about biochemical pathways and later went on to teach over 200 students in my medical school. I was intrigued by how applicable this was in hem/onc.
7 days to go for
@ASCO
#ASCO23
!
Plan your meeting and be ready to get lost in
#data
and McCormick! Well, one of them we can prepare for!
👀 the floorplan for McCormick at
#ASCO23
! 📍🗺️ Plus, check out where all the exciting exhibit booths will be! 🎪🔬
Big thanks to
@montypal
Happening LIVE:
@bensolomon1
takes the stage to present 5 yr updates from the CROWN study at
#ASCO24
#lcsm
-mPFS still not reached w/ lorlatinib
-LONGEST PFS in mNSCLC & for all targeted therapies
A true achievement for our patients with lung cancer
@OncoAlert
@LungCancerRx
6:30am : Admitted a patient to the ICU.
7:30am: ‘Home and packed.
8:00am: Friend who was meant to take me to the airport overslept.
8:30am:Uber arrived to take me to the airport
9:18am: Successfully checked in and hopefully to board soon to present at
#ASCO22
#ASCOiSpy
While residency had its challenges, it has always been the patients who solidified my interest in the field of
#hemonc
. I put myself to work immediately and worked on several research projects during residency.
We are very excited to announce our incoming chief fellow for 2023-24,
@RoloffGreg
! We're looking forward to an exciting year with you and for our incoming first-year fellows!
@UChicagoHemOnc
I’m honored to be invited to serve as a member of the
#ASCO
Trainee & Early Career Advisory Group
@ASCOTECAG
! Thankful for this opportunity to work with exceptional colleagues to support the professional development of trainees and early career oncologists!
@ASCO
@MDAndersonNews
Thank you to everyone who stopped by my poster yesterday. Manuscript is almost ready. You can read the full abstract here:
#ASCOiSpy
#ASCO22
@HemOncFellows
We're all so excited to be at ASCO at the end of the week! There are a whole lot of presentations, posters, and other sessions our amazing faculty & team members will be speaking at! Check out the list here!
#ASCO2023
#ASCO23
#OncologyInnovation
#ForefrontOfOncology
The correct answer to this question was smoldering myeloma.
Time for an educational 🧵for trainees/health care folks of all specialties about how we diagnose myeloma!
What are CRAB criteria? How is anemia defined? (Key to this Q)
Whats the deal with "SLiM" criteria?
#mmsm
One of my submitted abstracts at ASH in Blood Supplemental Nov issue
#medtwitter
#WomenInMedicine
#Oncology
#hematology
Racial Disparity in Mortality Rates Among Black and White Americans with Multiple Myeloma | Blood | American Society of Hematology
I am honored to serve as the Vice President and Chief Medical Officer for
#CHIHealth
Physician Enterprise Midwest. I am excited about the opportunity to support Physicians, Advanced Practice Providers (APPs) and Patient Care.
#helloHumanKindness
#CHIhealth
#CommonSpiritHealth
@loconte
@HemOncFellows
@IMCreighton
Your mind is in the same place as ours. The NCDB is unable to provide such fine details but that would be an excellent explanation for why uninsured patients were more likely to receive pall care than privately insured patients.
My J1 visa waiver was approved!
I’m happy to share that I will be joining
@DartmouthCancer
Main Campus as a Thoracic Oncologist!
I’m grateful to stay at my fellowship institution! Thank you to my mentors Drs. Dragnev/Vahdat, my husband Hugo, family & friends for your support!